As previously described in a series of alerts by Frier Levitt, since the declaration of a federal public health emergency (“PHE”), healthcare providers have operated under a variety of waived or relaxed regulatory requirements, particularly as... Read More
In 2021, the New Jersey Office of Attorney General (“NJAG”) entered into three settlement agreements with various healthcare entities over alleged violations of the Health Insurance Portability and Accountability Act (“HIPAA”). Of note, in... Read More
On December 16, 2021, the Department of Health and Human Services, Office of Inspector General (“OIG”) issued a report analyzing nationwide trends in genetic tests for which payments were made under Medicare Part B. The OIG report follows a... Read More
The Department of Justice recently announced that a compounding pharmacy owner was convicted, as part of his role in a telehealth “scheme” of 22 counts of: (i) mail fraud; (ii) conspiracy to commit health care fraud; and, (iii) introduction of a... Read More
On November 22, 2021, the U.S. Attorney’s Office for the Western District of Wisconsin announced that Dr. Ravi Murali, a Wisconsin physician, was sentenced to 54 months in prison as part of his role in a scheme to defraud Medicare. According to... Read More
On November 10, 2021, the U.S. Department of Health and Human Services, Office of Inspector General (“OIG”), published an Advisory Opinion (AO# 21-15) regarding a proposal to employ a Certified Registered Nurse Anesthetist (“CRNA”), on a... Read More
Last month, the Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) issued a report that identified deficiencies in the ability of states to root out fraud, waste, and abuse in Medicaid mental health services... Read More
Recently, a media organization obtained the medical records of 281,000 patients from an individual who hacked a telemedicine platform. The platform specifically catered to patients seeking Ivermectin and Hydroxychloroquine prescriptions. The hack... Read More
On October 5, 2021, the U.S. Department of Health and Human Services, Office of the Inspector General (“OIG”), published an Advisory Opinion (AO# 21-14) regarding a proposal to extend an existing discount program for chiropractic patients to... Read More
Earlier this summer, the U.S. Food and Drug Administration (“FDA”) issued a notice, as required by federal law, that describes the agency’s intent to conduct research examining “how firms communicate about prescription drugs from the... Read More
